JUN 08, 2021 9:52 AM PDT

THC Level in Body Fluids Is Not a Good Marker of Impairment

WRITTEN BY: Angela Dowden

It’s not easy to tell how impaired a person will be based on how much THC they have in their body a study has found. The research was funded by a National Institute of Justice grant awarded to RTI International scientists who carried out the research. 

In the research, 20 people who either ate or vaporized cannabis with varying levels of THC were then tested with sobriety and cognitive tests.

Study participants’ cognitive and psychomotor functioning were negatively impacted after all oral and vaped doses of cannabis over 5 milligrams.

For vaped THC doses over 5 milligrams, the greatest cognitive and psychomotor effects were observed between zero and two hours, returning to baseline after four hours.

For orally consumed THC doses, cognitive and psychomotor effects were observed one hour after administration and peak effects were seen about five hours after administration. It took longer with oral THC for functioning to return to normal — 8 hours.

However, even though all those that received doses higher than 5 milligrams of THC experienced observable impairment, THC levels in body fluids didn’t correlate accurately with indicators of intoxication and impairment.

In other words, some participants with higher levels of THC had low levels of impairment and the opposite also occurred.

“Many of their study participants had significantly decreased cognitive and psychomotor functioning even when their blood, urine, and oral fluid contained low levels of THC,” the RTI International researchers said.

In addition, the study found that standardized field sobriety tests commonly used to detect driving under the influence of drugs or alcohol, were useless at detecting marijuana intoxication. In a tweet the NIJ said that various tests, including standing on one leg, balancing and walking and turning, “were not sensitive to cannabis intoxication for any of the study participants.” 

Alternatively, Druid, a highly accurate, 3-minute smartphone app based on neuroscientific research, tests for impairment due to any cause, including marijuana. It represents a paradigm shift in testing — from drug testing to impairment testing.

A previous study found that low-level THC consumption has an impact that is "modest in magnitude and like that seen in drivers with a 0.05%” blood alcohol concentration”.

Of course, this doesn’t mean that it is safe to drive after taking cannabis — if anything this study suggests using extra caution as there’s no telling how strongly you will be impaired.

 

Sources: NIJ, Marijuana Moment

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
NOV 18, 2021
Immunology
Could Maternal Antibodies Contribute to Autism Development?
NOV 18, 2021
Could Maternal Antibodies Contribute to Autism Development?
Pregnant mothers pass on oxygen and nutrients to their developing babies while shuttling away waste products from the fe ...
NOV 24, 2021
Plants & Animals
A Plant-Based Antiviral for COVID-19 Infection
NOV 24, 2021
A Plant-Based Antiviral for COVID-19 Infection
Vaccines to combat the COVID-19 pandemic have been available for sometime, and have proved highly effective in preventin ...
NOV 29, 2021
Genetics & Genomics
A CRISPR-Based Technique to Make New Antibiotics
NOV 29, 2021
A CRISPR-Based Technique to Make New Antibiotics
There are many bacterial organisms, and they can live cooperatively, or they can battle one another. They are also capab ...
NOV 29, 2021
Cell & Molecular Biology
Researchers Discover a New Type of Cell in the Retina
NOV 29, 2021
Researchers Discover a New Type of Cell in the Retina
Many types of cells in the eye were identified 100 years ago. But researchers found something new there.
NOV 30, 2021
Cannabis Sciences
Terpene-Mediated Modulation of Cannabinoid Activity
NOV 30, 2021
Terpene-Mediated Modulation of Cannabinoid Activity
A popular theory – the “entourage effect” – has been gaining traction amongst the cannabis scien ...
DEC 03, 2021
Drug Discovery & Development
FDA approves new imaging drug to make ovarian cancer tumors glow.
DEC 03, 2021
FDA approves new imaging drug to make ovarian cancer tumors glow.
Earlier this week, the United States Food and Drug Administration (FDA) announced its approval for a novel dru ...
Loading Comments...